Emerging Pathologies in Cardiology

1. Front Matter

   Pages I-XV

   PDF

2. Emerging Concepts in the Assessment of Acute Coronary Syndromes and Global Cardiovascular Risk

   1. Front Matter

      Pages 1-1

      PDF

   2. Pathogenetic and Immunological Paradigm of Atherosclerotic Plaque

      • G. Calcara, C. Corno

      Pages 3-9

   3. Are a Single Measurement of Troponin-I and C-Reactive Protein of Clinical Significance in Patients with Acute Coronary Syndromes?

      • L. Oltrona, R. Pirola

      Pages 11-16

   4. New Strategies for Treating Myocardial Infarctions

      • F. Chiarella, A. Nicolino, K. Paonessa, F. Rossi

      Pages 17-21

   5. Tirofiban and NSTE-ACS: The Current Perspective

      • C. Cavallini

      Pages 23-30

   6. Acute Coronary Syndromes and Diabetes: How Much Can We Intervene?

      • F. Bovenzi, L. De Luca, R. Adorisio

      Pages 31-40

   7. Spinal Cord Stimulation in Refractory Coronary Artery Disease: The Last Resort?

      • H. Theres, S. Eddicks, M. Schenk, K. Maier-Hauff, C. Spies, G. Baumann

      Pages 41-52

   8. Guidelines for Antihypertensive Treatment: The Debate on the Choice of Antihypertensive Drugs

      • A. Salvetti, L. Ghiadoni, G. Salvetti

      Pages 53-61

   9. Aspirin and Cardiovascular Prevention in the Guidelines and in the Real World

      • G. Di Pasquale, P.C. Pavesi, G. Casella

      Pages 63-74

   10. Serial Changes in Left Ventricular Mass in Hypertension: Prognostic Impact

       • P. Verdecchia, F. Angeli, M.G. Sardone, R. Gattobigio

       Pages 75-81

3. Atrial Fibrillation: The Actual Clinical Approach

   1. Front Matter

      Pages 83-83

      PDF

   2. New Approach in the Prevention of Atrial Fibrillation: Role of Angiotensin II Antagonists

      • P. Verdecchia, F. Angeli, M. G. Sardone, R. Gattobigio

      Pages 85-90

   3. Role of Echocardiography in the Management of Atrial Fibrillation Patients

      • F. Antonini-Canterin, G. Allocca, D. Rivaben, R. Korcova-Miertusova, R. Piazza, M. Brieda et al.

      Pages 91-97

   4. Pharmacological Prevention of Arrhythmic Recurrences

      • G. Chiaranda, M.L. Cavarra, C.L. Romeo, M. Chiaranda, T. Regolo

      Pages 99-106

   5. Timing and Typology of Cardio-Embolic Prevention in Patients with Atrial Fibrillation

      • G. Di Pasquale, G. Casella, P.C. Pavesi

      Pages 107-114

   6. Non-Electric Treatment of Atrial Fibrillation: When Not to Treat?

      • R.F.E. Pedretti

      Pages 115-118

   7. The Role of Imaging in Catheter Ablation of Atrial Fibrillation

      • J. Kautzner, P. Peichl, H. Mlcochova

      Pages 119-128

   8. Atypical Atrial Flutter

      • A.S. Montenero

      Pages 129-134

   9. Advances in Surgical Treatment of Atrial Fibrillation

      • L. Patanè, A. Cavallaro

      Pages 135-151

Clinical practice is evolving at a rapid pace,nowhere more so than in the field of cardiology.Acute Coronary Syndromes, Sudden Cardiac Death, Heart Failure, Atrial Fibrillation,Syncope,and Prevention of Global Cardiovascular Risk are the main Emerging Pathologies to which many investigators are addressing their researches. Less than 10 years ago, some of them were considered of relevance only to internists, and some others as a common benign arrhythmia or an ineluctable illness. Today, their prevalence amongst the population represents one of the major public health problems at the beginning of the third millen- um. The need to have a state of the art overview of the epidemiology,physiopat- logical and electrogenetic mechanisms, diagnosis, pharmacological or electrical treatment,prognosis,patient management in and out of hospital,organisational and economical implications of these emerging pathologies and the success of the previous edition inspired us to organise the second edition of this biannual International Meeting. This book contains the Proceedings of the Mediterranean Cardiology Meeting held in Taormina, Italy, 7–9 April 2005. Like the previous volume, it boasts the participation of many nationally and internationally renowned spe- ers in the field of clinical and interventional cardiology who will interact actively with the delegates.

• Angiotensin II
• CRT
• Stent
• ablation
• atrial fibrillation
• cardiac resynchronization
• cardiovascular
• emerging pathologies
• heart failure

• Cardiology Division, S. Luigi — S.Currò Hospital, Catania, Italy

  M. M. Gulizia

Policies and ethics